Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

ICU TopicsPharmacology

ICU · Pharmacology

Toxicology Antidotes — ICU

Also known as Antidotes · Naloxone · N-acetylcysteine · Flumazenil · Digoxin Fab · Fomepizole · Methylene blue · Hydroxocobalamin · Lipid emulsion · High-dose insulin euglycaemia therapy · Atropine + pralidoxime · Sodium bicarbonate · Deferoxamine · Succimer · Folinic acid · Andexanet alfa · Idarucizumab · Protamine · Vitamin K · Prothrombin complex concentrate

ICU toxicology antidotes organised by toxin: naloxone (opioids), flumazenil (benzodiazepines - caution seizures), N-acetylcysteine (paracetamol - nomogram-driven), digoxin Fab (life-threatening digoxin toxicity), atropine + pralidoxime (organophosphates - before aging), fomepizole/ethanol (methanol/ethylene glycol - alcohol dehydrogenase inhibition), sodium bicarbonate (TCA Na-channel blockade + salicylate urine alkalinisation), methylene blue (methaemoglobinaemia - NOT G6PD), hydroxocobalamin/sodium thiosulfate/dicobalt EDTA (cyanide), calcium + high-dose insulin euglycaemia therapy + lipid emulsion (CCB/BB), octreotide (sulfonylurea), deferoxamine (iron), succimer/EDTA/BAL (lead), folinic acid/leucovorin (methotrexate), vitamin K/PCC/andexanet/idarucizumab (warfarin and DOAC reversal), protamine (heparin), oxygen/hyperbaric (carbon monoxide). Lipid rescue therapy for lipophilic drug overdose.

high55 referencesUpdated 26 July 202642 min readSource-verified · Sept 2026

Checked against its sources on 1 Sept 2026

Practise this topic

  • 8 MCQs

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

CICMFFICMEDIC

Red flags

  • Flumazenil precipitates seizures — avoid in mixed overdose (especially TCA co-ingestion) and chronic benzodiazepine users
  • NAC anaphylactoid reaction common in first 2 h (rate-related) — slow/stop infusion, give antihistamine, restart at half rate; non-IgE mediated so does NOT contraindicate completion
  • Methylene blue causes haemolysis in G6PD deficiency — screen before giving if possible; alternative is ascorbic acid or exchange transfusion
  • Sodium bicarbonate is the antidote for BOTH TCA cardiotoxicity (Na-channel blockade — wide QRS) AND salicylate poisoning (urine alkalinisation) — but the TARGETS differ (blood pH 7.50 for TCA vs urine pH >7.5 for salicylate)
  • Hydroxocobalamin turns skin, urine, plasma red-orange for days — not a side effect to chase; also interferes with co-oximetry and many lab assays (carboxyhaemoglobin, liver function)
  • Pralidoxime must be given BEFORE the organophosphate AGES (irreversibly binds AChE) — dimethyl compounds age in minutes, diethyl in hours
  • Andexanet alfa carries a 24-h restriction window vs PCC which is immediate — andexanet causes heparin-resistant anticoagulation monitoring (elevated anti-Xa is spurious)
  • Lipid emulsion can cause ARDS, pancreatitis, fat overload — not a benign rescue; reserve for refractory lipophilic overdose
On this page
Study tools

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

CICMFFICMEDIC

Red flags

  • Flumazenil precipitates seizures — avoid in mixed overdose (especially TCA co-ingestion) and chronic benzodiazepine users
  • NAC anaphylactoid reaction common in first 2 h (rate-related) — slow/stop infusion, give antihistamine, restart at half rate; non-IgE mediated so does NOT contraindicate completion
  • Methylene blue causes haemolysis in G6PD deficiency — screen before giving if possible; alternative is ascorbic acid or exchange transfusion
  • Sodium bicarbonate is the antidote for BOTH TCA cardiotoxicity (Na-channel blockade — wide QRS) AND salicylate poisoning (urine alkalinisation) — but the TARGETS differ (blood pH 7.50 for TCA vs urine pH >7.5 for salicylate)
  • Hydroxocobalamin turns skin, urine, plasma red-orange for days — not a side effect to chase; also interferes with co-oximetry and many lab assays (carboxyhaemoglobin, liver function)
  • Pralidoxime must be given BEFORE the organophosphate AGES (irreversibly binds AChE) — dimethyl compounds age in minutes, diethyl in hours
  • Andexanet alfa carries a 24-h restriction window vs PCC which is immediate — andexanet causes heparin-resistant anticoagulation monitoring (elevated anti-Xa is spurious)
  • Lipid emulsion can cause ARDS, pancreatitis, fat overload — not a benign rescue; reserve for refractory lipophilic overdose
The one-paragraph antidote framework

The poisoned patient is climbed in four fixed steps — resuscitation, decontamination, enhanced elimination, then the specific antidote — and the antidote is given only when the toxin is known or the toxidrome pins it down, never as a shotgun. Opioids get naloxone titrated to respiratory rate; benzodiazepines get flumazenil only in a pure, non-tolerant overdose; paracetamol gets N-acetylcysteine off the nomogram; digoxin gets Fab for an arrhythmia or a potassium over 6 mmol/L; organophosphates get atropine plus pralidoxime before aging; methanol and ethylene glycol get fomepizole plus cofactors plus dialysis; tricyclics get sodium bicarbonate to a blood pH of 7.50; salicylates get bicarbonate to a urine pH over 7.5 plus dialysis; methaemoglobinaemia gets methylene blue, not in G6PD deficiency; cyanide gets hydroxocobalamin; and calcium-channel or beta-blocker overdose gets calcium, high-dose insulin euglycaemia, then lipid.[1]

Meet the patient

A 19-year-old lands in resus at 3am, GCS 8, empty blister packs of paracetamol spilling from her pockets and the time of the last dose uncertain. She is somewhere around eight hours into a staggered overdose, and the question that decides her next hour is the one that decides every tox case: which antidote, and is the clock already too late for decontamination.[1]

Hold those two questions — the antidote and the clock — and the whole topic slots into place beneath them.[1]

ICU Fellowship (CICM) Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the ICU Fellowship (CICM) fellowship library.

Sign in to continueSee pricing
References55ShowHide
  1. [1]Rumack BH, et al. Acetaminophen overdose. 662 cases with evaluation of oral acetylcysteine treatment Arch Intern Med, 1981.PMID 7469629
  2. [2]Prescott LF, et al. The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage Eur J Clin Pharmacol, 1989.PMID 2598989
  3. [3]Brent J, et al. Fomepizole for the treatment of ethylene glycol poisoning. Methylpyrazole for Toxic Alcohols Study Group N Engl J Med, 1999.PMID 10080845
  4. [4]Brent J, et al. Fomepizole for the treatment of methanol poisoning N Engl J Med, 2001.PMID 11172179
  5. [5]Antman EM, et al. Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study Circulation, 1990.PMID 2188752
  6. [6]Knudsen K, Abrahamsson J Epinephrine and sodium bicarbonate independently and additively increase survival in experimental amitriptyline poisoning Crit Care Med, 1997.PMID 9142034
  7. [7]Knudsen K, et al. Effects of magnesium sulfate and lidocaine in the treatment of ventricular arrhythmias in experimental amitriptyline poisoning in the rat Crit Care Med, 1994.PMID 8125001
  8. [8]Baud FJ, et al. Elevated blood cyanide concentrations in victims of smoke inhalation N Engl J Med, 1991.PMID 1944484
  9. [9]Borron SW, Baud FJ Antidotes for acute cyanide poisoning Curr Pharm Biotechnol, 2012.PMID 22352728
  10. [10]Clifton J 2nd, Leikin JB Methylene blue Am J Ther, 2003.PMID 12845393
  11. [11]Boyle PJ, et al. Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses J Clin Endocrinol Metab, 1993.PMID 8445035
  12. [12]Krenz JR, et al. An Overview of Hyperinsulinemic-Euglycemic Therapy in Calcium Channel Blocker and β-blocker Overdose Pharmacotherapy, 2018.PMID 30141827
  13. [13]Schult RF, et al. Evaluation of high-dose insulin/euglycemia therapy for suspected β-blocker or calcium channel blocker overdose following guideline implementation Am J Health Syst Pharm, 2022.PMID 34957477
  14. [14]Fettiplace MR, et al. The Mechanisms Underlying Lipid Resuscitation Therapy Reg Anesth Pain Med, 2018.PMID 29356774
  15. [15]Weinberg G Lipid rescue resuscitation from local anaesthetic cardiac toxicity Toxicol Rev, 2006.PMID 17192120
  16. [16]Connolly SJ, et al. Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors N Engl J Med, 2016.PMID 27573206
  17. [17]Pollack CV Jr, et al. Idarucizumab for Dabigatran Reversal N Engl J Med, 2015.PMID 26095746
  18. [18]Dargan PI, et al. An evidence based flowchart to guide the management of acute salicylate (aspirin) overdose Emerg Med J, 2002.PMID 11971828
  19. [19]Christensen H, et al. European Stroke Organisation Guideline on Reversal of Oral Anticoagulants in Acute Intracerebral Haemorrhage Eur Stroke J, 2019.PMID 31903428
  20. [20]O'Grady JG, et al. Early indicators of prognosis in fulminant hepatic failure Gastroenterology, 1989.PMID 2490426
  21. [21]Saari TI, et al. Clinical Pharmacokinetics and Pharmacodynamics of Naloxone Clin Pharmacokinet, 2024.PMID 38485851
  22. [22]Williams K, et al. Evidence-Based Guidelines for EMS Administration of Naloxone Prehosp Emerg Care, 2019.PMID 30924736
  23. [23]Penninga EI, et al. Adverse Events Associated with Flumazenil Treatment for the Management of Suspected Benzodiazepine Intoxication - A Systematic Review with Meta-Analyses of Randomised Trials Basic Clin Pharmacol Toxicol, 2016.PMID 26096314
  24. [24]Veiraiah A, et al. Flumazenil use in benzodiazepine overdose in the UK: a retrospective survey of NPIS data Emerg Med J, 2012.PMID 21785147
  25. [25]Bateman DN, et al. New regimens for intravenous acetylcysteine, where are we now? Clin Toxicol (Phila), 2016.PMID 26666290
  26. [26]Yarema M, et al. Anaphylactoid Reactions to Intravenous N-Acetylcysteine during Treatment for Acetaminophen Poisoning J Med Toxicol, 2018.PMID 29423816
  27. [27]Schmidt LE, et al. Fewer adverse effects associated with a modified two-bag intravenous acetylcysteine protocol compared to traditional three-bag regimen in paracetamol overdose Clin Toxicol (Phila), 2018.PMID 29792347
  28. [28]Moss MJ, et al. Assessment of high-dose acetylcysteine in acute high-risk paracetamol (acetaminophen) ingestion Clin Toxicol (Phila), 2024.PMID 39051728
  29. [29]Bateman DN, et al. Impact of reducing the threshold for acetylcysteine treatment in acute paracetamol poisoning: the recent United Kingdom experience Clin Toxicol (Phila), 2014.PMID 25200454
  30. [30]Widemann BC, Adamson PC Understanding and managing methotrexate nephrotoxicity Oncologist, 2006.PMID 16794248
  31. [31]Ramsey LB, et al. Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance Oncologist, 2018.PMID 29079637
  32. [32]Juurlink DN, et al. Extracorporeal Treatment for Salicylate Poisoning: Systematic Review and Recommendations From the EXTRIP Workgroup Ann Emerg Med, 2015.PMID 25986310
  33. [33]Boehnert MT, Lovejoy FH Jr Value of the QRS duration versus the serum drug level in predicting seizures and ventricular arrhythmias after an acute overdose of tricyclic antidepressants N Engl J Med, 1985.PMID 4022081
  34. [34]Pai K, et al. Optimising alkalinisation and its effect on QRS narrowing in tricyclic antidepressant poisoning Br J Clin Pharmacol, 2022.PMID 34312917
  35. [35]Bradberry SM, et al. Management of the cardiovascular complications of tricyclic antidepressant poisoning: role of sodium bicarbonate Toxicol Rev, 2005.PMID 16390221
  36. [36]Mégarbane B Treatment of patients with ethylene glycol or methanol poisoning: focus on fomepizole Open Access Emerg Med, 2010.PMID 27147840
  37. [37]Borron SW, et al. Prospective study of hydroxocobalamin for acute cyanide poisoning in smoke inhalation Ann Emerg Med, 2007.PMID 17481777
  38. [38]Chan BS, Buckley NA Digoxin-specific antibody fragments in the treatment of digoxin toxicity Clin Toxicol (Phila), 2014.PMID 25089630
  39. [39]Glatstein M, et al. Octreotide for the treatment of sulfonylurea poisoning Clin Toxicol (Phila), 2012.PMID 23046209
  40. [40]Baranwal AK, et al. Acute iron poisoning: management guidelines Indian Pediatr, 2003.PMID 12824662
  41. [41]Bradberry S, et al. Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning Clin Toxicol (Phila), 2009.PMID 19663612
  42. [42]Steiner T, et al. Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial Lancet Neurol, 2016.PMID 27302126
  43. [43]Eddleston M, et al. Management of acute organophosphorus pesticide poisoning Lancet, 2008.PMID 17706760
  44. [44]Buckley NA, et al. Oximes for acute organophosphate pesticide poisoning Cochrane Database Syst Rev, 2011.PMID 21328273
  45. [45]Chiew AL, et al. Updated guidelines for the management of paracetamol poisoning in Australia and New Zealand Med J Aust, 2020.PMID 31786822
  46. [46]St-Onge M, et al. Experts Consensus Recommendations for the Management of Calcium Channel Blocker Poisoning in Adults Crit Care Med, 2017.PMID 27749343
  47. [47]Lee SH, Sohn JT Mechanisms underlying lipid emulsion resuscitation for drug toxicity: a narrative review Korean J Anesthesiol, 2023.PMID 36704816
  48. [48]Gosselin S, et al. Evidence-based recommendations on the use of intravenous lipid emulsion therapy in poisoning Clin Toxicol (Phila), 2016.PMID 27608281
  49. [49]Meamar R, et al. Intravenous Lipid Emulsion in Beta-Blocker With or Without Calcium Channel Blocker Toxicity: A Systematic Review of Human Case Reports and Series J Appl Toxicol, 2026.PMID 42365995
  50. [50]Nendumba G, et al. Use of intravenous lipid emulsions in drug-induced toxicities: a 2025 narrative review Ann Intensive Care, 2025.PMID 41247632
  51. [51]Levy JH, et al. What's fishy about protamine? Clinical use, adverse reactions, and potential alternatives J Thromb Haemost, 2023.PMID 37062523
  52. [52]Koscielny J, et al. How Do I Reverse Oral and Parenteral Anticoagulants? Hamostaseologie, 2020.PMID 32455460
  53. [53]Baud FJ, et al. Value of lactic acidosis in the assessment of the severity of acute cyanide poisoning Crit Care Med, 2002.PMID 12352039
  54. [54]Liebelt EL, et al. ECG lead aVR versus QRS interval in predicting seizures and arrhythmias in acute tricyclic antidepressant toxicity Ann Emerg Med, 1995.PMID 7618783
  55. [55]Wong A, et al. Early Cessation of Acetylcysteine Treatment After Paracetamol Overdose (NACSTOP 2): A Non-Inferiority Randomised Controlled Trial Med J Aust, 2026.PMID 41549406

Test yourself

Practise what you just read

  • 8 MCQs
ICU Fellowship (CICM) Pro

$29/ monthor $279 / year

The complete ICU Fellowship (CICM) library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousTherapeutic plasma exchange (plasmapheresis) in ICUPharmacologyNextAcute Severe Anticoagulation Reversal — Warfarin, DOACs & Heparin in the ICUhaematology-coagulation